Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093210
Status:
COMPLETED
Last Update Posted:
2007-12-05
First Post:
2004-10-04
Brief Title:
Study Evaluating of Recombinant Human Factor IX BeneFIX and a New Formulation of BeneFIX rFIX-R in Moderate to Severe Hemophilia B
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-09
Completion Date Type:
ACTUAL
First Submit Date:
2004-10-04
First Submit QC Date:
October 6 2004
Study First Post Date:
2004-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-03
Last Update Post Date:
2007-12-05
Last Update Post Date Type:
ESTIMATED